Filter
5277
Filtered Results: 5277
Text search:
Drug
Management
Featured
Recommendations
497
New Publications
1483
Language
Document type
No document type
3283
Studies & Reports
719
Guidelines
704
Manuals
220
Strategic & Response Plan
159
Fact sheets
69
Training Material
66
Situation Updates
22
Infographics
13
Resource Platforms
10
Online Courses
8
Brochures
3
App
1
Countries / Regions
India
339
Kenya
161
Global
153
South Africa
134
Ethiopia
127
Uganda
121
Western and Central Europe
114
Nigeria
111
Nepal
102
Tanzania
91
Liberia
90
Sierra Leone
87
Malawi
85
Zambia
84
Myanmar / Burma
73
Africa
71
Ghana
69
Bangladesh
65
Latin America and the Carribbean
65
Eastern Europe
61
Rwanda
59
Namibia
51
Ukraine
50
Philippines
44
Zimbabwe
37
Cambodia
37
Indonesia
35
Asia
35
South–East Asia Region
33
Lesotho
32
Russia
32
Congo, Democratic Republic of
29
Botswana
28
Syria
25
Mozambique
24
Germany
23
Brazil
23
Senegal
22
Burkina Faso
20
Eswatini/ Swaziland
20
South Sudan
18
East and Southern Africa
17
West and Central Africa
16
Middle East and North Africa
16
Haiti
15
USA
14
Cameroon
14
Colombia
14
Guinea
13
Eastern Europe and Central Asia
12
Tajikistan
12
Pakistan
11
Albania
11
Thailand
10
Peru
9
Venezuela
9
Afghanistan
8
Argentina
8
Vietnam
8
China
7
Sudan
7
Benin
7
Laos
7
Georgia
7
Yemen
6
Western Pacific Region
6
Armenia
6
Iraq
5
Central African Republic
5
North Macedonia
5
Mexico
5
Sri Lanka
5
Chile
5
Moldova
5
Spain
5
Somalia
4
Jordan
4
Turkey
4
Ecuador
4
El Salvador
4
Bolivia
4
Libya
4
Angola
4
Madagascar
4
Paraguay
4
Bhutan
4
United Kingdom
4
Mali
3
Guinea-Bissau
3
Lebanon
3
Papua New Guinea
3
Fiji
3
Palestine
3
Timor Leste/ East Timor
3
Estonia
3
Iran
3
Jamaica
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Switzerland
2
Honduras
2
Southern Africa
2
Canada
2
Romania
2
Kyrgyzstan
2
Kazakhstan
2
North America
2
Gabon
2
Belgium
2
France
2
Belarus
2
Niger
1
Egypt
1
Chad
1
Gambia
1
Singapore
1
Austria
1
Serbia
1
Hungary
1
Greece
1
Guatemala
1
Nicaragua
1
Solomon Islands
1
Poland
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Australia
1
Uruguay
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
2122
Clinical Guidelines
509
Public Health
266
Women & Child Health
215
Key Resources
108
Capacity Building
77
Pharmacy & Technologies
61
Annual Report MEDBOX
1
Toolboxes
TB
551
HIV
543
Mental Health
485
AMR
274
COVID-19
231
Pharmacy
178
NTDs
162
NCDs
121
Caregiver
112
Rapid Response
93
Ebola
83
Planetary Health
68
Conflict
60
Refugee
59
Global Health Education
52
Disability
51
Health Financing Toolbox
30
Natural Hazards
22
Specific Hazards
22
Polio
21
Cholera
18
Zika
18
Social Ethics
10
Health Financing
1
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management...; veterinary public health services; and the provision of safe water, sanitation and hygiene. In 2015 alone nearly one billion people were treated for at least one disease and significant gains were achieved in relieving the symptoms and consequences of diseases for which effective tools are scarce; important reductions were achieved in the number of new cases of sleeping sickness, of visceral leishmaniasis in South-East Asia and also of Buruli ulcer.
The report also considers vector control strategies and discusses the importance of the draft WHO Global Vector Control Response 2017–2030.
The report also considers vector control strategies and discusses the importance of the draft WHO Global Vector Control Response 2017–2030.
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case ... - early diagnosis and treatment - is a critical component of malaria prevention and control. To achieve the main objective of reducing malaria morbidity and prevention of malaria mortality, the availability of safe, effective, affordable and accessible anti-malarial drugs is a prerequisite.
Overview
Learning objectives
• Name the general principles of essential care and practice.
• Name management principles of priority MNS conditions.
• Use effective communication skills in interactions with people with MNS conditions.
• ...
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. ...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with ...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeter...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
This policy guideIine is intended for use by healthcare professionals invoIved in the management of Covid-19 in South Africa. The document provides guidance on diagnostic tests available, on antigen test performance and accessibility. 1t focuses on ...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced C...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interve...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International ... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone refere...
The following information provides guidance to health care providers attending to the medical needs of HIV-infected adults (including pregnant women) or children displaced from disaster areas who have not yet secured HIV care in the areas where they have relocated.
(*)
- HHS Panel on Antiretrov...
